tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IONS Stock Latest News

Ionis Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
RatingsIonis Pharmaceuticals: Strong Financial Performance and Promising Pipeline Justify Buy Rating
11d ago
IONS
Ionis Pharmaceuticals price target raised to $50 from $45 at H.C. Wainwright
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $50 from $45 at H.C. Wainwright
12d ago
IONS
Ionis Pharmaceuticals: Strong Buy Rating Backed by Robust Drug Performance and Strategic Market Expansion
PremiumRatings
Ionis Pharmaceuticals: Strong Buy Rating Backed by Robust Drug Performance and Strategic Market Expansion
12d ago
IONS
Ionis Pharmaceuticals price target lowered to $64 from $65 at Guggenheim
PremiumThe Fly
Ionis Pharmaceuticals price target lowered to $64 from $65 at Guggenheim
12d ago
IONS
Ionis Pharmaceuticals: Strong Q1 Performance and Future Growth Potential Drive Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strong Q1 Performance and Future Growth Potential Drive Buy Rating
12d ago
IONS
Ionis Pharmaceuticals Reports Strong Q1 2025 Results
PremiumCompany AnnouncementsIonis Pharmaceuticals Reports Strong Q1 2025 Results
12d ago
IONS
Ionis Pharmaceuticals’ Earnings Call Highlights Growth Amid Challenges
Premium
Company Announcements
Ionis Pharmaceuticals’ Earnings Call Highlights Growth Amid Challenges
12d ago
IONS
Ionis Pharmaceuticals: Strong Financial Performance and Strategic Partnerships Justify Buy Rating Despite Adjusted Price Target
Premium
Ratings
Ionis Pharmaceuticals: Strong Financial Performance and Strategic Partnerships Justify Buy Rating Despite Adjusted Price Target
12d ago
IONS
Ionis Pharmaceuticals: Strong Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strong Performance and Promising Pipeline Justify Buy Rating
12d ago
IONS
Ionis Pharmaceuticals: Strong Q1 Performance and Promising Outlook Drive Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strong Q1 Performance and Promising Outlook Drive Buy Rating
12d ago
IONS
Ionis Pharmaceuticals ups FY25 revenue view to $725M-$750M from at least $600M
PremiumThe Fly
Ionis Pharmaceuticals ups FY25 revenue view to $725M-$750M from at least $600M
13d ago
IONS
Ionis Pharmaceuticals reports Q1 EPS (93c), consensus ($1.03)
PremiumThe Fly
Ionis Pharmaceuticals reports Q1 EPS (93c), consensus ($1.03)
13d ago
IONS
IONS Earnings this Week: How Will it Perform?
PremiumPre-EarningsIONS Earnings this Week: How Will it Perform?
15d ago
IONS
Ionis Pharmaceuticals’ Tryngolza: Promising Treatment for Severe Hypertriglyceridemia with Strong Market Potential
Premium
Ratings
Ionis Pharmaceuticals’ Tryngolza: Promising Treatment for Severe Hypertriglyceridemia with Strong Market Potential
28d ago
IONS
Buy Rating for Ionis Pharmaceuticals: Promising Potential of Olzesarsen in sHTG Treatment
Premium
Ratings
Buy Rating for Ionis Pharmaceuticals: Promising Potential of Olzesarsen in sHTG Treatment
28d ago
IONS
Promising Potential of Ionis Pharmaceuticals’ Olezarsen in sHTG Market with Competitive Pricing and Strong Market Potential
PremiumRatings
Promising Potential of Ionis Pharmaceuticals’ Olezarsen in sHTG Market with Competitive Pricing and Strong Market Potential
28d ago
IONS
Ionis Pharmaceuticals: Promising Market Growth with Tryngolza Approval and Advancing Clinical Trials
PremiumRatings
Ionis Pharmaceuticals: Promising Market Growth with Tryngolza Approval and Advancing Clinical Trials
28d ago
IONS
Ionis Pharmaceuticals price target lowered to $52 from $55 at Morgan Stanley
PremiumThe Fly
Ionis Pharmaceuticals price target lowered to $52 from $55 at Morgan Stanley
1M ago
IONS
Ionis Pharmaceuticals: Promising Growth with New Product Launches and Strong Pipeline
PremiumRatings
Ionis Pharmaceuticals: Promising Growth with New Product Launches and Strong Pipeline
1M ago
IONS
Reddit initiated, Roku upgraded: Wall Street’s top analyst calls
PremiumThe FlyReddit initiated, Roku upgraded: Wall Street’s top analyst calls
1M ago
DG
GM
Ionis Pharmaceuticals: Poised for Growth with Promising RNA-Targeted Therapeutics and Upcoming Drug Launches
Premium
Ratings
Ionis Pharmaceuticals: Poised for Growth with Promising RNA-Targeted Therapeutics and Upcoming Drug Launches
1M ago
IONS
Ionis Pharmaceuticals initiated with a Buy at H.C. Wainwright
Premium
The Fly
Ionis Pharmaceuticals initiated with a Buy at H.C. Wainwright
1M ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >